Skip to content
★ Sign in to follow
Sarana Meditama logo

Sarana Meditama Stock: price and insider trades · Indonesia

ID·Mcap IDR 4.8T

No insider purchase over the last 90 days. The latest, by PT SARANA MEDITAMA METROPOLITAN, TBK., was filed 13 Jul 2026.

Sarana Meditama: what insiders have been doing

Sarana Meditama is a listed company based in Indonesia. Its insiders report their share dealings to OJK / IDX. 1 insider has disclosed 2 filings since 8 November 2025.

Only purchases show up on the open market, 2 purchases in all worth €2.4M, filed by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 1 major shareholder among the declarants. The largest single trade was a purchase of €1.8M by PT Sarana Meditama Metropolitan, Tbk., published on 13 July 2026, equal to 0.73% of the market capitalisation.

Compared with its exchange (245 companies, median 3 filings), a count of 2 filings is below the norm. The full history, which starts in 2026, counts 2 purchases against no sales.

The last insider purchase was made public on 13 July 2026, 117 days ago.

Every figure here comes from the filings published by OJK / IDX and describes the past, not future prices; it is not investment advice.

Key facts

Headquarters: Indonesia

Source: Wikidata (CC0).

Insider Decl.
2
Thresholds
n/a
Buy Volume
€2M
2 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
PT Sarana Meditama Metropolitan, Tbk.2 buys

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,293 of 26,912 companies
31.4
score / 100
Value
30
Quality
33
FCF yld-0.2%
Earn yld0.8%
EV/EBITDA23.6x
ROE0.6%
Gross mgn30%
Net mgn1.6%
Debt/EBITDA4.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

IDR 280.00
Analyst consensus
·
Income statement
RevenueIDR 1.9T
Gross profitIDR 552.6B30% margin
EBITDAIDR 206.9B11% margin
Net incomeIDR 30.1B1.1% margin
Valuation
PER (trailing)237.3x
P/Book1.3x
Beta0.03
Balance sheet & cash
Market capIDR 4.8T
Total debtIDR 978.2B
Free Cash Flow-IDR 8.3B
Debt / Equity24%
Profitability & ownership
ROE0.7%
ROA1.2%
% insiders89.0%
% institutions0.1%
Last declaration on 13 July 2026
Declarations2 total
  • ▲
    Related company / holdingExecutives
    36B IDR13IDX
    18,300,000 shares@ IDR 1,950.000.73% mcap73.0% of flowCommon SharesIDXIDX:LK-13072026-0010-1#0
    Canonical exit: 6 Oct 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    13B IDR9IDX
    8,000,000 shares@ IDR 1,660.000.27% mcap27.0% of flowCommon SharesIDXIDX:LK-13072026-0010-1#1
    Canonical exit: 7 Oct 2026 (T+90)

2 of 2 declarations

About Sarana Meditama

Sarana Meditama is a company listed on the XIDX market, specializing in the healthcare sector.